Report of consensus panel 5 from the 11th international workshop on Waldenstrom's macroglobulinemia on COVID-19 prophylaxis and management-Reference-Cited by-同舟云学术

Report of consensus panel 5 from the 11th international workshop on Waldenstrom's macroglobulinemia on COVID-19 prophylaxis and management

Published:2023-03 Issue:2 Volume:60 Page:107-112
ISSN:0037-1963
Container-title:Seminars in Hematology
language:en
Short-container-title:Seminars in Hematology

Author:

Terpos E.^ORCID,Branagan A.R.,García-Sanz R.,Trotman J.,Greenberger L.M.,Stephens D.M.,Morel P.,Kimby E.,Frustaci A.M.,Hatjiharissi E.,San-Miguel J.,Dimopoulos M.A.,Treon S.P.,Leblond V.

Publisher

Elsevier BV

Subject

Hematology

Reference40 articles.

1. Consensus statement on the management of Waldenstrom Macroglobulinemia patients during the COVID-19 pandemic;Talaulikar;Hemasphere,2020

2. Risk and outcome of breakthrough COVID-19 infections in vaccinated patients with cancer: real-world evidence from the national COVID cohort collaborative;Song;J Clin Oncol,2022

3. Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines;Fernandes;Ann Med,2022

4. Breakthrough SARS-CoV-2 infections among patients with cancer following two and three doses of COVID-19 mRNA vaccines: a retrospective observational study from the COVID-19 and Cancer Consortium;Choueiri;Lancet Reg Health,2023

5. SARS-CoV-2 humoral responses following booster BNT162b2 vaccination in patients with B-cell malignancies;Terpos;Am J Hematol,2022

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current approach to Waldenström macroglobulinemia;Blood Reviews;2023-11

2. Characteristics and outcomes of COVID-19 in patients with plasma cell dyscrasias during the first Omicron wave in Beijing since December 2022: a retrospective study at a National Clinical Research Center for Hematologic Disease;Annals of Hematology;2023-07-12